Mustang Bio, Inc.
MBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001680048
No open-market purchases or sales by Mustang Bio, Inc. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $378.3K in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Mustang Bio, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- +1 vs. Q3 2023
- Shares held
- 1.03M
- +440.2K (+74.2%) vs. Q3 2023
- Total value
- $1.40M
- +$173.4K (+14.2%) vs. Q3 2023
- New holders
- 4
- 5 more added
- Sold out
- 3
- 6 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $378.3K |
| Q1 2026 | 22 | $369.8K |
| Q4 2025 | 25 | $541.9K |
| Q3 2025 | 20 | $426.5K |
| Q2 2025 | 17 | $70.9K |
| Q1 2025 | 16 | $142.3K |
| Q4 2024 | 30 | $826.5K |
| Q3 2024 | 25 | $207.2K |
| Q2 2024 | 29 | $372.6K |
| Q1 2024 | 30 | $773.1K |
| Q4 2023 | 28 | $1.40M |
| Q3 2023 | 27 | $1.22M |
| Q2 2023 | 28 | $3.94M |
| Q1 2023 | 52 | $3.62M |
| Q4 2022 | 66 | $4.71M |
| Q3 2022 | 70 | $6.80M |
| Q2 2022 | 77 | $10.3M |
| Q1 2022 | 85 | $25.3M |
| Q4 2021 | 88 | $46.4M |
| Q3 2021 | 83 | $71.8M |
| Q2 2021 | 98 | $85.9M |
| Q1 2021 | 99 | $80.6M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Mustang Bio, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 302 | $0 | 0.00% | −36−10.7% | Reduced |
| CWM, LLC | 133 | $0 | 0.00% | 00.0% | Unchanged |
| Clear Point Advisors Inc. | 1 | $1 | 0.00% | +1 | New |
| Pacific Capital Wealth Advisors, Inc | 6 | $8 | 0.00% | +6 | New |
| Oliver Lagore Vanvalin Investment Group | 9 | $12 | 0.00% | 00.0% | Unchanged |
| Carmichael Hill & Associates, Inc. | 33 | $45 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 56 | $76 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 133 | $180 | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 136 | $184 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 150 | $203 | 0.00% | +9+6.4% | Added |
| Bank of America Corp | 211 | $285 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 361 | $487 | 0.00% | 00.0% | Unchanged |
| US Bancorp | 1,000 | $1.35K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,000 | $1.35K | 0.00% | +570+132.6% | Added |
| Tower Research Capital LLC (TRC) | 6,367 | $8.60K | 0.00% | +5,474+613.0% | Added |
| FMR LLC | 7,203 | $9.72K | 0.00% | 00.0% | Unchanged |
| Macquarie Group Ltd | 7,999 | $11.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 11,763 | $15.9K | 0.00% | −199−1.7% | Reduced |
| State Street Corp | 16,017 | $21.6K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 17,042 | $23.0K | 0.00% | +17,042 | New |
| HighTower Advisors, LLC | 19,413 | $27.0K | 0.00% | −11−0.1% | Reduced |
| Renaissance Technologies LLC | 39,690 | $54.0K | 0.00% | −4,500−10.2% | Reduced |
| Susquehanna International Group, LLP | 42,620 | $57.5K | 0.00% | +10,000+30.7% | Added |
| Geode Capital Management, LLC | 49,796 | $67.2K | 0.00% | 00.0% | Unchanged |
| Koss-Olinger Consulting, LLC | 96,366 | $130.0K | 0.01% | −3,634−3.6% | Reduced |
| BlackRock Inc. | 100,449 | $135.6K | 0.00% | −156−0.2% | Reduced |
| Vanguard Group Inc | 179,562 | $242.4K | 0.00% | +1,985+1.1% | Added |
| Armistice Capital, LLC | 435,764 | $588.3K | 0.02% | +435,764 | New |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −17,539−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −4,135−100.0% | Sold out |
| NBC Securities, Inc. | 0 | $0 | 0.00% | −400−100.0% | Sold out |